MedTech

Viewing related articles

Would you like to influence the future of drug device combination products?

Drug device combination products are an increasingly important part of drug life-cycle management. Allied Market Research estimates that the sector will be worth $139bn by 2025, with growth driven by a rise in chronic diseases and increased focus on home-based healthcare. This is an innovative sector with increasingly complex devices being used to deliver drugs – yet there are no harmonized international standards to guide development....

read more

MedTech considers drug device challenges

Following a positive response to BioPhorum’s proposal for a new collaboration in the combination products space, representatives from eight BioPhorum member companies gathered in early May to agree a plan for developing a MedTech Phorum program. Ten stakeholders joined the kick-off call and brought more than 125 years of combination product experience spanning functions across the full product lifecycle, including device design and engineering,...

read more

Navigating the maze of medical technology regulation: a solo voyage or a team effort?

Medical technology is a global business, generating annual revenues of over $400bn. The sector encompasses a broad range of technologies: from in-vitro diagnostics and diagnostic test equipment to medical devices that include toothbrushes, MRI scanners, orthopaedic joint replacements and drug delivery devices. It is also a sector characterized by high innovation: it attracts the largest number of applications to the European Patent Office of...

read more